Edwards Lifesciences 2005 Annual Report"
With more than 5,400 employees now working in Edwards’
operations globally, we continue extending our connections
and contributions throughout the world. Fueled by the continued
increasing demand for our innovative PERIMOUNT tissue heart valves,
in June we opened a new heart valve manufacturing plant in Singapore
to serve growing numbers of customers and patients.
Additionally, we announced the creation of The Edwards Lifesciences Fund, a $20
million charitable fund intended to support advancements in knowledge and improvements
in quality of life, focusing primarily on cardiovascular disease and the communities
where our employees live and work. The 17 organizations that received funds from
our first grant cycle will help realize the Fund’s mission by assisting
underserved individuals around the world.
